The pathogenesis of metabolic syndrome in patients with psoriasis is believed to have a connection with an increase in adipocytokines such as tumor necrosis factor-α (TNF-α) and adiponectin [2–4]. The gene discussed is TNF; the disease is metabolic syndrome.